|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net premiums earned | |||||
| Net investment income | |||||
| Net realized gains | |||||
| Net unrealized gains on equity securities | |||||
| Consolidated revenue | |||||
| Losses and settlement expenses | |||||
| Policy acquisition costs | |||||
| Insurance operating expenses | |||||
| Interest expense on debt | |||||
| General corporate expenses | |||||
| Total expenses | |||||
| Equity in earnings of unconsolidated investees | |||||
| Earnings before income taxes | |||||
| Income tax expense: | |||||
| Current | |||||
| Deferred | |||||
| Income tax expense | |||||
| Net earnings | |||||
| Other comprehensive earnings (loss), net of tax | |||||
| Comprehensive earnings | |||||
| Basic net earnings per share | |||||
| Diluted net earnings per share | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic | |||||
| Diluted |
Loading...
